Professional Documents
Culture Documents
Brig YK Goorha*, Maj Prabal Deb+, Lt Col T Chatterjee#, Col PS Dhot**, Brig RS Prasad, VSM++
Abstract
Elimination of, especially transfusion-transmitted diseases (HIV and hepatitis) and leucocyte-
mediated
allosensitisation, is an important goal of modern transfusion medicine. The problems and high cost
factor involved in collecting
and storing human blood and the pending world-wide shortages are the other driving forces
contributing towards the development
of blood substitutes. Two major areas of research in this endeavour are haemoglobin-based
oxygen carriers (HBOCs) and
perfluorochemicals. Even though they do not qualify as perfect red blood cell substitutes, these
‘oxygen carrying solutions’ have many potential clinical and non clinical usages.
These can reach tissues more easily than normal red cells and can deliver oxygen
directly. These are not without adverse effects, and extensive clinical trials are being conducted to
test their safety and efficacy.
New understandings on the mode of action of these products will help to define their utility and
application. Only after successful
clinical trials can they be used for patient management, after approval by the FDA.
Introduction
pasteurisation.
aggregation) [1-3].
The first step in the pursuit for red cell substitute was
*Commandant, Armed Forces Medical Store Depot, Delhi Cantt - 110 010, +Graded Specialist
(Pathology), IMTRAT, C/o 99 APO,
#Classified Specialist (Pathology), Base Hospital, Delhi Cantt, **Commanding Officer, Armed Forces
Transfusion Centre, Delhi Cantt,
++Deputy Director Medical Services, Head Quarter DGBR, Kashmir House, DHQPO, New Delhi - 110
011.
Goorha, et al
[5].
MODIFIED HAEMOGLOBIN
POLYMERISED HAEMOGLOBIN :
Recombinant Haemoglobin :
Artificial Blood
nanocapsules [8].
Toxicity
[1,10,14,15].
Perfluorocarbons :
Toxicity
Table 1
1.
Therapy
(a)
surgery); anaemia.
(b)
failure.
(c)
coronary artery.
(d)
HACO.
(e)
Aid for organ recovery : acute renal failure; acute hepatic failure;
acute pancreatitis.
(f)
(g)
2.
3.
4.
5.
Non-Clinical Applications
1.
Culture medium
2.
calibrator
3. Bioreactor
1.
Oxygen absorbent
2.
radiotherapy or chemotherapy.
Goorha, et al
imaging [8,22-25].
Present status
Artificial Blood
The physiological mechanisms are still incompletely
Conclusion
References
1.
3.
4.
1990;87:8521-5.
5.
1992;10:557-9.
6.
7.
8.
Chang TM. Red blood cell substitutes. Baillieres Best Pract
9.
11. O’Hara JF, Colburn WA, Tetzlaff JE, Novick AC, Angermeier
2001;29(1):5-18.
Surg 1984;119:721-5.
Northoff H. A system
Biofizika 2001;46(1):5-33.
2000;28(3):894-6.
1995;259-75.
Goorha, et al
Proc 1975;34:1525-8.
28. Lee DH, Blajchman MA. Platelet substitutes and novel platelet
ATTENTION SUBSCRIBERS
Subscription rates revised from 01 Apr 02. The new subscription rates are :
(i)
(ii)
iii)
Individual)
(iv)
Institutional)
(v)
(Foreign countries)
Note
1. Please make your cheques or bank drafts in favour of Medical Journal Armed Forces
India, payable at Pune. For outstation cheques add Rs. 30/- as bank commission.
2. Intimate non-reciept of issue within three months from the month of publication.